Mogy Joel R Investment Counsel Inc. Has $33.60 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mogy Joel R Investment Counsel Inc. raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 67,838 shares of the medical equipment provider’s stock after purchasing an additional 932 shares during the quarter. Intuitive Surgical accounts for 2.2% of Mogy Joel R Investment Counsel Inc.’s portfolio, making the stock its 17th largest holding. Mogy Joel R Investment Counsel Inc.’s holdings in Intuitive Surgical were worth $33,598,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $25,000. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. Global Financial Private Client LLC raised its stake in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 38 shares during the last quarter. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Hurley Capital LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president now directly owns 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Gary Loeb sold 1,700 shares of the firm’s stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president now directly owns 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock valued at $2,611,577 in the last ninety days. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $522.41 on Thursday. The firm has a fifty day moving average of $524.49 and a two-hundred day moving average of $538.83. The stock has a market capitalization of $187.24 billion, a price-to-earnings ratio of 81.50, a PEG ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the company posted $1.50 earnings per share. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Royal Bank of Canada cut their price objective on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Truist Financial cut their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a “hold” rating to a “sell” rating and reduced their price target for the stock from $515.00 to $440.00 in a research report on Monday. Barclays lowered their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Finally, Citigroup reaffirmed a “buy” rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.